What does Celestial Biolabs Limited do?

Celestial Biolabs Limited is a Hyderabad-based company incorporated in 1997, engaged in the herbal and nutraceutical products sector. Despite being delisted from stock exchanges by SEBI in 2015, the company reportedly maintains active operational status.

Why was Celestial Biolabs delisted by SEBI in 2015?

Celestial Biolabs Limited was delisted by SEBI in 2015. SEBI-initiated delistings (compulsory delisting) typically occur due to non-compliance with SEBI listing obligations, failure to meet minimum public shareholding norms, non-filing of financial results, or other regulatory violations. The specific grounds for the 2015 delisting are not confirmed in publicly available records.

Is Celestial Biolabs Limited currently operational?

According to available information, Celestial Biolabs Limited has an 'active' corporate status as per MCA records despite being delisted from exchanges in 2015. This means the company exists as a legal entity and has not been struck off or wound up, though its operational activity level is not confirmed.

When was Celestial Biolabs incorporated?

Celestial Biolabs Limited was incorporated in 1997 in Hyderabad, Telangana (then Andhra Pradesh), under CIN L72200TG1997PLC028374.

What are herbal and nutraceutical products?

Herbal products are derived from plant-based sources and include Ayurvedic medicines, herbal extracts, and botanical formulations. Nutraceuticals are food-derived products with health benefits including vitamins, minerals, dietary supplements, and functional food ingredients. India is one of the world's largest producers and consumers of herbal and nutraceutical products.

What does the 'L' prefix in Celestial Biolabs CIN mean?

The 'L' prefix in CIN L72200TG1997PLC028374 conventionally denotes that the company was listed on a stock exchange at the time of or after incorporation. Celestial Biolabs was indeed listed but was subsequently delisted by SEBI in 2015.

How do I buy Celestial Biolabs unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Celestial Biolabs?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Celestial Biolabs shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Celestial Biolabs Unlisted Share Price | Buy Celestial Biolabs Pre-IPO Shares — wisefolio

Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Talk to us

Celestial Biolabs Unlisted Share Price | Buy Celestial Biolabs Pre-IPO Shares — wisefolio | wisefolio

Investment Thesis

Celestial Biolabs Limited is a Hyderabad-based herbal and nutraceutical company incorporated in 1997 that was compulsorily delisted by SEBI in 2015. Despite maintaining 'active' corporate status per MCA records, the near-face-value share price of ₹1.21 reflects extreme investor skepticism about the company's current viability. While India's herbal and nutraceutical sector offers genuine long-term growth prospects, Celestial Biolabs' regulatory history (SEBI delisting), minimal share price, and limited public disclosures make it a very high-risk position. Investors should treat this as a distressed or speculative position and conduct thorough independent legal and financial due diligence before any exposure.

Pros

ISIN INE221I01017 confirmed; listed on BSE (532871) and NSE (CELESTIAL) — exchange-regulated.
Diversified pharma portfolio: Ayurvedic products, feed supplements, herbal formulations, enzymes, nutraceuticals — multiple growth segments.
Hyderabad location — India's pharma/biotech hub with deep R&D talent and manufacturing ecosystem.
Authorized ₹29 Cr; paid-up ₹22.59 Cr — well-subscribed capital for a niche biotech/herbal company.

Cons

Revenue only ₹0.14 Cr — near-zero operational activity despite large authorized capital; commercial scale not achieved.
Multiple name changes (Celestial Technologies → Celestial Labs → Celestial Biolabs) indicate frequent business model pivots.
Ayurvedic/herbal market is intensely competitive with Dabur, Himalaya, Patanjali dominating; small players struggle for shelf space.
Net worth only ₹3.35 Cr vs ₹29 Cr authorized capital — substantial capital not deployed productively.

Business Segments

Ayurvedic & Herbal Products

Manufacturing of Ayurvedic products; herbal, enzyme, and nutraceutical health products for men, women, and children.

Feed Supplements

Trading of animal and livestock feed supplement formulations.

Revenue Model

Celestial Biolabs Limited generates (or historically generated) revenue through the manufacture and distribution of herbal products, nutraceuticals, and Ayurvedic formulations to wholesale distributors, healthcare retailers, pharmacies, and potentially direct-to-consumer channels. Given the post-delisting status and near face-value share price, current revenue levels and operational activity cannot be independently confirmed.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds10

Growth Plans

India's herbal and nutraceutical market is growing rapidly driven by wellness trends and government support for AYUSH sector

A potential restructuring, change of management, or re-compliance process could revive investor interest

Growing export demand for Indian herbal products in Western and Asian markets

Industry Tailwinds

India's herbal and nutraceutical market is growing rapidly driven by wellness trends and government support for AYUSH sector

Recent Developments

SEBI-ordered compulsory delisting

Celestial Biolabs Limited was compulsorily delisted by SEBI in 2015 due to non-compliance with listing regulations. The company's shares were removed from the stock exchange, and it transitioned to unlisted status. The company's active MCA status indicates it has not been wound up.

2015

Frequently Asked Questions

About Celestial Biolabs

Celestial Biolabs Limited is a Hyderabad-based biopharmaceutical company incorporated in 1997 and listed on both BSE and NSE (CIN: L72200TG1997PLC028374). The company operates in the herbal formulations, nutraceuticals, and feed supplement segment — developing and marketing plant-based health products for human and animal use. Product categories include herbals, enzymes, and nutraceuticals aligned with India's growing wellness and natural health market. Hyderabad is India's pharmaceutical capital — home to companies like Dr. Reddy's Laboratories, Aurobindo Pharma, and hundreds of API and formulation manufacturers — giving Celestial Biolabs proximity to a rich talent pool and supplier network for pharmaceutical and biotech development. The company is GMP (Good Manufacturing Practice) certified and ISO 9001:2008 certified, indicating it meets quality standards for pharmaceutical production. Despite its BSE and NSE listings, Celestial Biolabs operates at very small scale — Screener.in records revenue of approximately ₹0.14 crore, which represents near-dormant operations. The company's RocketReach profile cites $6 million (~₹50 crore) in 2025 annual revenue, but this discrepancy may reflect different reporting methodologies. At either scale, the company is a micro-cap entity in the listed pharmaceutical universe. The nutraceuticals and herbal supplement market in India is growing rapidly, driven by post-COVID health awareness and growing demand for natural health solutions. Companies like Celestial Biolabs with GMP-certified manufacturing can potentially participate in this growth, though conversion from small-scale operations to meaningful market presence requires significant investment in product development, marketing, and distribution.

Key Milestones

Incorporated November 19, 1997 as Celestial Technologies Private Limited, Hyderabad (CIN: L72200TG1997PLC028374)

Common questions about unlisted shares

How do I buy Celestial Biolabs unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Celestial Biolabs Limited

How settlement works

Get price alerts for Celestial Biolabs Limited

Similar companies

Other ways to invest

Discuss Celestial Biolabs